#Health / Well-being #Therapeutics
- Bladder cancer
- Colon Cancer
- Covid – pulmonary infections
As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.Discover >
Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.Discover >
#Health / Well-being #Therapeutics
Production of BCG vaccines and BCG-based cancer and inflammation treatments, preparation and distribution of fresh log-phase BCG cultures.
Vaccinopole proposes mouse and guinea pig models for anti-cancer, anti-asthma and anti-inflammatory screening.
As of this writing, the company has completed 37 pharmaceutical research projects. Since 2011, it has been manufacturing BCG (Mycobacterium bovis BCG) products in Asia.
DESCRIPTION OF THE PRODUCTS / SERVICES / TECHNOLOGY
Thanks to its exceptional process (surface culture) for the industrial production of BCG, Vaccinopole has produced and distributed more than 20 million doses of BCG vaccine to prevent tuberculosis and 150,000 vials of intravesical BCG to treat superficial bladder cancer.
The company develops novel formulations for US patenting at Institut Pasteur Paris, taking aim at such diseases as invasive bladder cancer, colon cancer or inflammatory bowel disease.
Unprecedentedly in Europe, Vaccinopole is now preparing fresh log-phase BCG cultures for urology/oncology hospital practitioners.
ACCOMPLISHMENTS / COLLABORATIONS / HIGHLIGHTS
Because BCG has been shown to control lung inflammation and reduce mortality in COVID-19 pulmonary infection in more than 120 articles and two clinical trials, Vaccinopole is currently developing a new BCG formulation for intradermal injection to protect adults from this pandemic disease.
Whether for the preparation of seed lots, formulations, the development of lyophilization parameters, the technical training of production personnel, or the conceptualization of industrial-scale standard operating procedures (production, formulation, filling and packaging, quality control and assurance), Vaccinopole partners with international centers for research and production in the settings of tuberculosis and urological cancers.
Respecting its humanitarian mission of eradicating tuberculosis worldwide and benefiting from its high-yield mycobacteria culturing technology, Vaccinopole is looking to transfer its know-how in the industrial production of BCG vaccines to countries across the world, while respecting local economic, geographic and commercial conditions.
3, Square Auguste Renoir
5, rue Henri Desbruères,
Genopole Campus 1,
2, Chemin de Crève-Coeur
10380 Plancy l’Abbaye
In same field
CGenetix, is a medTech start-up developing in vitro medical diagnostic devices for the follow-up of transplant patients.Discover
Research & development for an in vitro diagnostic tool for endometriosisDiscover
Exosome Analytics develops techniques for EVs isolation and highly sensitive detection of protein markers on EVs for their application in liquid biopsy.Discover
Ciclix is a tech driven company specialized in process digitization for hospitals and focused on creating natural and efficient solutions for a variety of user profiles in the hospital environment.Discover
Echoliv is a MedTech startup that develops solutions based on artificial intelligence and applied to hepatic ultrasound. Our goal is to develop software to assist radiologists and hepatologists.Discover
– Characterization of antigen / antibody interactions (epitope / paratope) – Optimization of therapeutic antibodiesDiscover
Biotechnology, R&D, Drug development, oncology, obesity, infectious diseasesDiscover
Cell Environment is a company focusing on DNA damage detection involving unique and repeated sequences such as telomere and centromere sequences.Discover
Our mission is to improve the management of Red Blood Cell diseases and in particular Sickle Cell DiseaseDiscover
Artificial intelligence to optimize and accelerate the development of gene therapiesDiscover
Software for biomedical data analysisDiscover
Synsight is a company specializing in the discovery and preclinical development of new therapeutic molecules, based on a proprietary, integrated platform, combining artificial intelligence, molecular modeling and a functional experimental screening approach of High-Content Screening (HCS ).Discover
Design, manufacture and commercialization of in vitro diagnostic systems (instruments and reagents) for medical biology laboratories.Discover
Santen SAS has developed its own sales force to commercialize ophthalmic products in France while Novagali Innovation Center is a center of excellence for Santen Group dedicated to research and development of innovative ophthalmic treatments for all segments of the eye.Discover
Pharnext develops new therapies and biomarkers based on network pharmacology with a proprietary discovery platform. The company is focused on pathologies with high unmet medical needs. These include neurodegenerative, orphan and common diseases (Charcot-Marie-Tooth disease Type 1A, Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis (ALS)).Discover
PEP-Therapy develops innovative peptides as targeted therapies in oncology. The company operates a unique therapeutic technology based on cell penetrating & interfering peptides (CP&IP). These innovative molecules penetrate cells and specifically block relevant intracellular protein-protein interactions, thus inhibiting key pathological mechanisms.Discover
LPS-BioSciences is specialized in bacterial endotoxins. It combines an exclusive proprietary technology for endotoxin production and characterization. and its acquired experience in the fields of vaccines, diagnostics, and the food industry.Discover
IntegraGen’s mission is to translate molecular research to clinical practice through the identification of novel genetic biomarkers and the subsequent commercialization of molecular diagnostic tests based on these discoveries.Discover
Discovery, development and production of innovative therapies for rare genetic diseases, notably neuromuscular diseases.Discover
Enterome develops and commercializes therapies for disorders associated with disruption of the intestinal microbiota.Discover